---
$id: https://graph.org.ai/products/commodity/51282920
$type: Product
source: UNSPSC
code: "51282920"
title: "Garenoxacin"
class: "51282900"
classTitle: "Quinolone antibacterials"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Garenoxacin

**UNSPSC Code**: 51282920
**Class**: [Quinolone antibacterials](Quinolone antibacterials.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a quinolone antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V72H9867WB. European Medicines Agency schedules Garenoxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25475. Garenoxacin generally arises in the molecular formula C23H20F2N2O4. The term GARENOXACIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 17, no. 2, 2003, list 49.) Most nations schedule garenoxacin under HS 29334990 and SITC 51575. As of Q4 2014, GARENOXACIN remains the US FDA Preferred Term for this commodity. Garenoxacin bears US NLM identifiers UMLS ID C1507354 and NCI Concept Code C65800. SMILES: FC(F)OC1C2N(C3CC3)CC(C(=O)C2CCC1C1CC2C(C(NC2)C)CC1)C(=O)O.

